Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.
2.

An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.

Arora P, Elkin PL, Eberle J, Bono JJ, Argauer L, Murray BM, Ram R, Venuto RC.

BMC Nephrol. 2015 Dec 3;16:199. doi: 10.1186/s12882-015-0194-2.

3.

Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.

Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo AA, Murray BM, Tornatore KM, Blessios GA, Venuto RC.

Nephrol Dial Transplant. 2012 May;27(5):2077-83. doi: 10.1093/ndt/gfr608. Epub 2011 Nov 5.

PMID:
22058172
4.

Which direction is right for vascular access surveillance? A debate.

Abreo K, Allon M, Asif A, Atray N, Besarab A, Dember LM, Dixon BS, DeVita M, Kaufman J, Murray BM, Nguyen VD, Paulson WD, Ram SJ, Vachharajani T, Vesely TM, White JJ, Work J, Kennedy J.

Nephrol News Issues. 2010 Jun;24(7):30, 32, 34. No abstract available.

PMID:
20617629
5.

Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection.

Nainani N, Singh N, Shanahan T, Damodar A, Parimoo N, Ummadi S, Qazi Y, Murray BM, Tornatore KM, Ciccirella JC, Blessios GA, Venuto RC.

Transpl Immunol. 2009 Jan;20(3):113-7. doi: 10.1016/j.trim.2008.10.009. Epub 2008 Nov 6.

PMID:
18996198
6.

Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.

Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM.

J Am Board Fam Med. 2008 Nov-Dec;21(6):522-30. doi: 10.3122/jabfm.2008.06.080042.

7.

Screening for prophylactic intervention in failing hemodialysis grafts and fistulas.

Murray BM.

Saudi J Kidney Dis Transpl. 2004 Jul-Sep;15(3):305-20. No abstract available.

8.

Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.

Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.

Ann Pharmacother. 2007 Nov;41(11):1761-9. Epub 2007 Sep 25.

PMID:
17895328
9.

Comparison of access blood flow and venous pressure measurements as predictors of arteriovenous graft thrombosis.

Singh N, Ahmad S, Wienckowski JR, Murray BM.

J Vasc Access. 2006 Apr-Jun;7(2):66-73.

PMID:
16868899
10.

Access flow after angioplasty predicts subsequent arteriovenous graft survival.

Murray BM, Herman A, Mepani B, Rajczak S.

J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):303-8.

PMID:
16517776
11.

Delivery of predialysis care in an academic referral nephrology practice.

Murray BM, Malireddi K, Vavilala V.

Ren Fail. 2005;27(5):571-80.

PMID:
16152996
12.
13.

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.

Murray BM, Subramaniam S.

Transpl Infect Dis. 2004 Mar;6(1):3-9.

PMID:
15225220
14.

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.

Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, Murray BM, Barres B, Tessier-Lavigne M, Bernard CC.

Nat Neurosci. 2004 Jul;7(7):736-44. Epub 2004 Jun 6.

PMID:
15184901
15.

Why do grafts clot despite access blood flow surveillance?

Arbabzadeh M, Mepani B, Murray BM.

Cardiovasc Intervent Radiol. 2002 Nov-Dec;25(6):501-5. Epub 2002 Nov 6.

PMID:
12415418
16.

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.

Transpl Infect Dis. 2000 Sep;2(3):112-7.

PMID:
11429021
17.

Assessment of access blood flow after preemptive angioplasty.

Murray BM, Rajczak S, Ali B, Herman A, Mepani B.

Am J Kidney Dis. 2001 May;37(5):1029-38.

PMID:
11325686
18.

The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome.

Lamey PJ, Murray BM, Eddie SA, Freeman RE.

J Oral Pathol Med. 2001 Feb;30(2):121-4.

PMID:
11168857
19.
20.

Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.

Murray BM, Amsterdam D, Gray V, Myers J, Gerbasi J, Venuto R.

J Am Soc Nephrol. 1997 Sep;8(9):1448-57.

21.

Management of cytomegalovirus infection in solid-organ transplant recipients.

Murray BM.

Immunol Invest. 1997 Jan-Feb;26(1-2):243-55. Review. No abstract available.

PMID:
9037627
22.

Polymerase chain reaction assays for the detection of cytomegalovirus in organ and bone marrow transplant recipients.

Evans MJ, Edwards-Spring Y, Myers J, Wendt A, Povinelli D, Amsterdam D, Rittenhouse-Diakun K, Armstrong D, Murray BM, Greenberg SJ, Riepenhoff-Talty M.

Immunol Invest. 1997 Jan-Feb;26(1-2):209-29.

PMID:
9037625
23.

Post-transplant diabetes mellitus and methylprednisolone pharmacokinetics in African-American and Caucasian renal transplant recipients.

Tornatore KM, Biocevich DM, Reed KA, Tousley K, Gray V, Singh JP, Murray BM, Venuto RC.

Clin Transplant. 1995 Aug;9(4):289-96.

PMID:
7579735
24.

The cytomegalovirus-antigenemia assay in the diagnosis of posttransplant cytomegalovirus infection.

Murray BM, Brentjens J, Amsterdam D, Myers J, Gray V, Pawlowski I, Schewegler K, Singh JP, Venuto RC.

J Am Soc Nephrol. 1994 Feb;4(8):1615-22.

26.

Effect of dietary protein intake on renal growth: possible role of insulin-like growth factor-I.

Murray BM, Campos SP, Schoenl M, MacGillivray MH.

J Lab Clin Med. 1993 Dec;122(6):677-85.

PMID:
8245687
27.

Non-traumatic rhabdomyolysis complicating antihistamine overdose.

Frankel D, Dolgin J, Murray BM.

J Toxicol Clin Toxicol. 1993;31(3):493-6.

PMID:
8355326
28.

Differences in inositol phosphate production in rat tail artery and thoracic aorta.

Labelle EF, Murray BM.

J Cell Physiol. 1990 Sep;144(3):391-400.

PMID:
2391374
29.
30.

G protein control of inositol lipids in intact vascular smooth muscle.

LaBelle EF, Murray BM.

FEBS Lett. 1990 Jul 30;268(1):91-4.

31.

Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine.

Murray BM, Venuto RC, Kohli R, Cunningham EE.

Am J Kidney Dis. 1990 Jul;16(1):66-9.

PMID:
2368707
32.

Effect of protein intake on the autoregulation of renal blood flow.

Murray BM, Brown GP.

Am J Physiol. 1990 Jan;258(1 Pt 2):F168-74.

PMID:
2105662
33.

Clinically important interaction of cyclosporine and erythromycin.

Murray BM, Edwards L, Morse GD, Kohli RR, Venuto RC.

Transplantation. 1987 Apr;43(4):602-4. No abstract available.

PMID:
3576677
34.

Pressor resistance to vasopressin in sodium depletion, potassium depletion, and cirrhosis.

Murray BM, Paller MS.

Am J Physiol. 1986 Sep;251(3 Pt 2):R525-30.

PMID:
2875660
35.
36.

Effect of cyclosporine administration on renal hemodynamics in conscious rats.

Murray BM, Paller MS, Ferris TF.

Kidney Int. 1985 Nov;28(5):767-74.

38.

Renal dysfunction in animal models of cyclosporine toxicity.

Paller MS, Murray BM.

Transplant Proc. 1985 Aug;17(4 Suppl 1):155-9. Review. No abstract available.

PMID:
3895656
39.

The Soviet Union's Zond 5: Is It Also a Planetary Spacecraft?

Davies ME, Murray BM.

Science. 1968 Oct 11;162(3850):245-6. No abstract available.

PMID:
17779373

Supplemental Content

Loading ...
Support Center